Latest Breaking News On - Bionomics limited - Page 1 : comparemela.com

Investment Analysts Updated EPS Estimates for June 12th (BNOX, BRTX, CASY, CFG, CPLF, CWB, MAMA, NICE, NSSC, PDSB)

Investment Analysts’ updated eps estimates for Wednesday, June 12th: Bionomics (NASDAQ:BNOX) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $8.00 price target on the stock. BioRestorative Therapies (NASDAQ:BRTX) had its buy rating reaffirmed by analysts at Roth Mkm. Roth Mkm currently has a $15.00 price target on the stock. […]

William blairRoth mkmNews ratings for bionomics limited dailyCitizens financial groupJefferies financial group incRoyal bankNational bankshares incCanadian western bankCitigroup incMorgan stanleyInvestment analystRestorative therapiesGeneral storesJefferies financial groupFinancial groupNational bankshares

Bionomics Limited (NASDAQ:BNOX) Sees Large Decline in Short Interest

Bionomics Limited (NASDAQ:BNOX – Get Free Report) saw a significant decrease in short interest in May. As of May 15th, there was short interest totalling 95,400 shares, a decrease of 19.3% from the April 30th total of 118,200 shares. Based on an average trading volume of 110,300 shares, the short-interest ratio is currently 0.9 days. […]

Bionomics company profileExchange commissionBionomics limitedGet free reportFree reportBionomics daily

Bionomics : SECURITIES PURCHASE AGREEMENT - Form 6-K

SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT is made and entered into as of May 31, 2024 by and among Bionomics Limited, a public company incorporated under.

United statesNew yorkNew york stock exchangeCommonwealth of australiaSpyros papapetropoulosTheodorej ghorraNeither the companyGood laboratory practiceGroup incCompany counselInternational accounting standards boardCompany the first closing subscription amountLeerink partnersCompany constitutionFinancial action task force on money launderingAgreements of the company

Bionomics to Present at the 2024 American Society of Clinical Psychopharmacology Annual Meeting - Bionomics (NASDAQ:BNOX)

ADELAIDE, Australia and CAMBRIDGE, Mass., May 20, 2024 (GLOBE NEWSWIRE) Bionomics Limited (NASDAQ:BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in-class, allosteric ion

United kingdomMiami beachUnited statesSouth australiaSpyridon spyros papapetropoulosMerck co incLoews miami beach hotelBionomics limitedCompany annual report on formAmerican society of clinical psychopharmacologyBionomics or companyInvestor centerExchange commissionChief executive officerClinical psychopharmacologyAnnual meeting

Bionomics Limited (NASDAQ:BNOX) Sees Significant Increase in Short Interest

Bionomics Limited (NASDAQ:BNOX) Sees Significant Increase in Short Interest
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Bionomics limitedGet free reportFree reportBionomics daily